Abstract

CLC Number:

R541.6

[1]	LI Na. The Risk Assessment Value of Multi-parameter Echocardiography Score for Prognosis of Heart Failure Patients [J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(9): 169-173.
[2]	. [J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(7): 187-190.
[3]	. [J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(2): 154-157.
[4]	. [J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(21): 184-187.
[5]	. [J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(18): 29-31.
[6]	PENG Yan. The Values of Cardiac Ultrasound Parameter Integration System in Risk Assessment of Prognosis of Patients with Heart Failure at High Altitude [J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(16): 11-15.
[7]	. [J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(13): 59-62.
[8]	GUO Xue-feng. Dose Dependence of Valsartan Dose on Ventricular Vascular Coupling Index in Patients with Heart Failure [J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(10): 51-54.
[9]	. [J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(7): 179-182.
[10]	GUAN Jing-zhi, WANG Fei-fei, DAI Wen-jun, YUAN Shao-fei, SHI Lei. Impact of Sacubitril/Valsartan on the Treatment Effectiveness, Serum Sirtuin-4 and Beclin-1 Levels of Chronic Heart Failure Patients [J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(3): 184-188.
[11]	. [J]. ZHONGHUA YANGSHENG BAOJIAN, 2022, 40(18): 74-76.
[12]	LIU Yan-yan. Effects of Valsartan Combined with Spironolactone on Intractable Heart Failure,Coagulation Function and Cardiac Function [J]. ZHONGHUA YANGSHENG BAOJIAN, 2022, 40(17): 7-10.
[13]	. [J]. ZHONGHUA YANGSHENG BAOJIAN, 2022, 40(15): 58-60.
[14]	. [J]. ZHONGHUA YANGSHENG BAOJIAN, 2022, 40(15): 132-135.
[15]	Zhao Li-rong. Observation on the effect of exercise training in the treatment of elderly patients with chronic heart failure and sarcopenia [J]. ZHONGHUA YANGSHENG BAOJIAN, 2022, 40(11): 4-7.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments